Evidence map›Paper›PMID 27480097›Full record

ArticleUrolithiasis2017

The value of hypercalciuria in patients with osteopenia versus osteoporosis.

María Sierra Girón-Prieto, María Del Carmen Cano-García, Antonio Poyatos-Andújar, Salvador Arias-Santiago, Tomás de Haro-Muñoz, Miguel Arrabal-Martín, Miguel Ángel Arrabal-Polo

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Urolithiasis, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Protective Effects of Water Extract ofVeterinary sciences · 2021
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

María Sierra Girón-PrietoAtención Primaria, Granada, Programa de doctorado de medicina clínica y salud pública, Universidad de Granada, Granada, Spain.
María Del Carmen Cano-GarcíaUGC Urología intercentros, Hospital La Inmaculada, Huércal-Overa, Almeria, Spain.
Antonio Poyatos-AndújarUGC Análisis Clínicos, Hospital Santa Ana, Motril, Granada, Spain.
Salvador Arias-SantiagoDepartamento de Medicina, Universidad de Granada, Granada, Spain.
Tomás de Haro-MuñozUGC Análisis Clínicos intercentros, Hospital Universitario Granada, Granada, Spain.
Miguel Arrabal-MartínUGC Urología intercentros, Hospital Universitario Granada, Granada, Spain.
Miguel Ángel Arrabal-PoloUGC Urología intercentros, Hospital La Inmaculada, Huércal-Overa, Almeria, Spain. arrabalp@ono.com.
Complejo Hospitalario Universitario de Granada · ESHospital La Inmaculada · ESUniversidad de Granada · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to analyze the presence of lithogenic metabolic factors in the blood and urine of patients with osteopenia versus osteoporosis. This is a cross-sectional study including 67 patients who were divided into two groups according to the presence of either osteopenia or osteoporosis as measured by bone densitometry: group 1-40 patients with osteopenia (22 men and 18 women) and group 2-27 patients with osteoporosis (13 men and 14 women). Metabolic studies were performed on the blood and urine; statistical analysis was performed comparing means and conducting linear correlation and multivariate analyses with SPSS. Statistical significance was considered to be p ≤ 0.05. The mean age of patients in group 1 was 52.9 ± 12.8 years versus 50.3 ± 11.4 in group 2; the difference was not statistically significant. In group 2, higher levels of osteocalcin, β-crosslaps, urinary calcium, fasting urine calcium/creatinine, 24 h urine calcium/creatinine and 24 h oxaluria were observed compared to group 1. In the multivariate analysis, only the β-crosslaps and urinary calcium were independently associated with osteoporosis. It would be advisable to determine the urinary calcium levels in patients with osteoporosis since altered levels may necessitate modifying the diagnostic and therapeutic approach to osteoporosis.

Indexed as

AdultAgedBone and BonesBone Diseases, MetabolicCalciumCreatinineCross-Sectional StudiesDensitometryFemaleHumansHypercalciuriaMaleMiddle AgedOsteocalcinOsteoporosisCalciumCreatinineOsteocalcinBone markersCalciuriaOsteopeniaOsteoporosis

Identifiers

PMID27480097
OpenAlexW2483034546

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.